A 24-year-old primigravid woman at 35 weeks' gestation comes to the labor and delivery unit because of 6 hours of epigastric pain and nausea. Her prenatal course has been uncomplicated; blood pressure at her visit 2 weeks ago was 118/74 mm Hg. She takes only a prenatal vitamin. Her pulse is 92/min and blood pressure is 162/108 mm Hg; a repeat measurement 15 minutes later is 158/104 mm Hg. Examination shows right upper quadrant tenderness, 3+ patellar reflexes without clonus, and 1+ pedal edema. Fetal heart rate is 140/min with moderate variability and no decelerations; the cervix is 1 cm dilated and 50% effaced. Laboratory studies show a hemoglobin of 10.2 g/dL, platelet count of 78,000/mm3, AST of 240 U/L, ALT of 198 U/L, lactate dehydrogenase of 900 U/L, creatinine of 1.0 mg/dL, and a urine protein-to-creatinine ratio of 0.6. Peripheral blood smear shows schistocytes. Which of the following is the most appropriate next step in management?
- Betamethasone and expectant management until 37 weeks
- Platelet transfusion and repeat laboratory studies in 12 hours
- Emergency cesarean delivery
- Oral nifedipine and follow-up in 1 week
- Intravenous magnesium sulfate and induction of labor
Show the answer and explanation
Correct answer: E. Intravenous magnesium sulfate and induction of labor
New-onset severe-range hypertension after 20 weeks with thrombocytopenia, elevated transaminases, and microangiopathic hemolysis (schistocytes, elevated LDH) is HELLP syndrome, a severe form of preeclampsia. HELLP at or beyond 34 weeks is an indication for delivery regardless of fetal maturity, because expectant management risks abruption, hepatic rupture, DIC, and eclampsia. Management includes magnesium sulfate for seizure prophylaxis, antihypertensives for severe-range pressures, and delivery; with a reassuring fetal heart tracing and no obstetric contraindication, induction of labor is appropriate and cesarean delivery is reserved for usual obstetric indications. Corticosteroids for fetal lung maturity are not a reason to delay delivery at 35 weeks. Platelet transfusion is given for active bleeding or a count under 20,000 to 50,000 before cesarean, not as a substitute for delivery.
Why each option is right or wrong
- Betamethasone and expectant management until 37 weeksExpectant management is not appropriate for HELLP at 35 weeks; the definitive treatment is delivery.
- Platelet transfusion and repeat laboratory studies in 12 hoursPlatelets are transfused for bleeding or before surgery at very low counts; delaying delivery for repeat labs risks maternal deterioration.
- Emergency cesarean deliveryCesarean is not mandated by HELLP itself; vaginal delivery is preferred when the fetal status and cervix permit.
- Oral nifedipine and follow-up in 1 weekDischarge on an oral antihypertensive ignores a life-threatening maternal condition.
- Intravenous magnesium sulfate and induction of laborCorrect: HELLP syndrome at 34 weeks or beyond is managed with magnesium seizure prophylaxis and delivery, by induction when the fetus is reassuring.
HELLP syndrome or preeclampsia with severe features at 34 weeks or beyond: magnesium sulfate, control severe hypertension, and deliver.
References
- HELLP Syndrome (StatPearls) (NCBI Bookshelf)
- The HELLP syndrome (Acta Clin Belg 2010) (PubMed)